All sites C00-96,D32-33,D42-43,D45-47,D76 1492 89.7 1.7 3.3 1.0 4.2
Mouth, pharynx C00-14 34 100.0 - - - -
  Lip C00 6 100.0 - - - -
  Tongue C02 6 100.0 - - - -
  Mouth, other C03-06 8 100.0 - - - -
  Salivary glands C07-08 3 100.0 - - - -
  Pharynx C01,C09-14 12 100.0 - - - -
Digestive organs C15-26 292 82.9 0.7 8.5 1.6 6.3
  Oesophagus C15 22 95.5 - 0.9 0.9 2.7
  Stomach C16 34 92.9 - 2.4 0.6 4.2
  Small intestine C17 6 100.0 - - - -
  Colon C18 89 95.3 - 1.1 0.7 2.9
  Rectum, rectosigmoid C19-20 56 97.5 - 0.7 0.4 1.4
  Anus C21 1 100.0 - - - -
  Liver C22 25 73.2 0.8 16.3 4.1 5.7
  Gallbladder, bile ducts C23-24 10 48.1 3.8 28.8 5.8 13.5
  Pancreas C25 44 39.4 3.2 33.9 3.6 19.9
  Other digestive organs C26 4 50.0 - 10.0 5.0 35.0
Respiratory organs C30-39 168 78.8 6.5 6.4 1.3 6.9
  Nose, sinuses C30-31 3 100.0 - - - -
  Larynx, epiglottis C32 9 100.0 - - - -
  Lung, trachea C33-34 155 77.3 7.1 7.0 1.4 7.2
  Mediastinum, pleura C38 1 75.0 - - - 25.0
Bone C40-41 3 100.0 - - - -
Melanoma of the skin C43 65 99.7 - - - 0.3
Skin, non-melanoma C44 76 99.7 0.3 - - -
Mesothelioma C45 15 96.0 2.7 - - 1.3
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 7 100.0 - - - -
Breast C50 3 100.0 - - - -
Male genital organs C60-63 471 97.8 0.0 0.3 0.6 1.3
  Prostate C61 454 97.8 0.0 0.3 0.6 1.4
  Testis C62 13 100.0 - - - -
  Other male genital C60,C63 4 100.0 - - - -
Urinary organs C64-68 135 93.0 0.4 3.0 0.3 3.3
  Kidney C64 50 86.1 - 6.0 0.4 7.6
  Bladder and urinary tract2 C65-68 84 97.2 0.7 1.2 0.2 0.7
Eye C69 1 71.4 14.3 14.3 - -
Brain, central nervous system C70-72,D32-33,D42-43 42 87.0 - 5.3 1.9 5.8
Thyroid gland C73 9 100.0 - - - -
Other endocrine glands C74-75 2 75.0 - - - 25.0
Illdefined or unknown C76,C80 25 50.8 4.0 18.5 6.5 20.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 145 80.2 6.6 0.7 2.3 10.1
  Hodgkin lymphoma C81 7 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 64 97.8 0.9 - - 1.3
  Malignant immunoproliferative diseases C88 2 66.7 - - - 33.3
  Myeloma and other plasma cell tumors C90 19 63.8 8.5 4.3 5.3 18.1
  Leukaemia C91-95 34 65.7 17.2 - 2.4 14.8
  Myelodysplastic syndromes D46 7 27.8 5.6 2.8 11.1 52.8
  Myeloproliferaitive neoplasms D45,D47 12 77.0 9.8 - 6.6 6.6
Not included above
  Basal cell carcinoma of the skin 393 99.9 - - 0.1 -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.